Utah Medical Products (UTMD) Profit After Tax (2010 - 2026)

Utah Medical Products' Profit After Tax history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 44.11% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $10.3 million (down 24.36% YoY), while the FY2025 annual figure was $13.8 million, up 9.13% from the prior year.
• Profit After Tax for Q1 2026 stood at $2.1 million, down from $2.6 million in the prior quarter.
• The five-year high for Profit After Tax was $4.6 million in Q4 2022, with the low at $2.1 million in Q1 2026.
• The 5-year median for Profit After Tax is $3.8 million (2025), against an average of $3.6 million.
• The sharpest annual moves came in 2022 and 2026: Profit After Tax advanced 19.76% in 2022, then plunged 44.11% in 2026.
• Utah Medical Products' Profit After Tax stood at $4.6 million in 2022, then declined by 5.88% to $4.3 million in 2023, then slumped by 32.31% to $2.9 million in 2024, then decreased by 11.61% to $2.6 million in 2025, then declined by 18.09% to $2.1 million in 2026.
• Business Quant data shows UTMD's Profit After Tax at $2.1 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.